medicines


Articles

TPP free trade agreement would increase cost of medicine In Mexico, Peru, Chile, and other countries

4-Mar-2015 Latin Times TPP — the Trans-PacificPartnership — is making waves from Peru to Australia, concerning public health officials and consumer advocates.

  • 27-Jul-2011 NY Times
    A trade barrier to defeating AIDS

    The new strategy is to treat people in Egypt, Paraguay, Turkmenistan or China — middle-income countries, all — as if they or their governments could pay hundreds or even thousands of dollars a year each for AIDS drugs.

  • 25-Jul-2011 ULB
    Impact Assessment of CETA IPR chapter

    CETA IPR chapter will likely have a slight positive effect on specific industries in the EU, such as agri-food companies using geographical indications. It would also benefit the Canadian publishing industry and the innovative pharmaceutical industry. At the same time, an IPR chapter in CETA could lead to notable negative effects in Canada, for example via higher prices on educational and pharmaceutical products.

  • 18-Jul-2011 ANGOP
    Président de l’IAS pour plus de facilités d’accès aux médicaments contre le sida

    Le président de l’Association Internationale du Sida (IAS), l’Ougandais Elly Katabira, a invité dimanche, tous les pays du monde de faciliter l’accès aux médicaments contre la maladie, y compris les génériques, par des nouvelles lois ou règlements.

  • 17-Jul-2011
    SOCMA offers support for free trade pacts with South Korea, Panama, and Colombia

    The Society of Chemical Manufacturers and Affiliates (SOCMA) issued its support this week of the passage of pending free-trade agreements (FTA) with South Korea, Panama and Colombia by two Congressional committees. SOCMA is the US-based trade association representing custom and batch manufacturers, including contract manufacturers of fine chemicals, pharmaceutical intermediates, and active pharmaceutical ingredients.

  • 15-Jul-2011 Public Service Europe
    EU-India FTA - the data exclusivity dilemma

    Conflict between European and Indian pharma industries might be played out again in FTAs with other nations

  • 10-Jul-2011
    "BRICS can ensure affordable drugs"

    While ‘data exclusivity’ clauses will not feature in the India-European Union free trade agreement (FTA), the threat posed by the impending deal to the world’s supply of cheap generic drugs is far from over.

  • 8-Jul-2011
    Korea-EU FTA to put Seoul at public health crossroads

    Pharmaceuticals might not have been the most discussed sector before the Korea-European Union Free Trade Agreement came into effect from July 1.

  • 6-Jul-2011 Reuters
    Millions will die if India stops AIDS drugs — UN

    Millions of people dependent on life-saving generic drugs to treat HIV/AIDS will die if India stops producing cheap drugs for the disease due to its trade deal with the European Union, the head of UNAIDS warned on Tuesday.

  • 3-Jul-2011 ACT UP-Paris
    ACT UP-Paris wakes up the European Commissioner for Trade in Belgium

    This morning, in a small town in the region of Gent, Belgium, activists from Act Up-Paris woke up the European Commissioner for Trade in front of his house. They unfurled a banner which said ‘De Gucht, AIDS accomplice’.

  • 29-Jun-2011 Prensa Libre
    EEUU - DR-CAFTA: TLC encarece medicamentos

    El relator especial de las Naciones Unidas sobre el Derecho a la Salud, Anand Grover, detectó el aumento en el precio de algunos medicamentos, debido al TLC con EE. UU., y sugiere la compra de fármacos genéricos.

  • 27-Jun-2011 Alternet
    5 WikiLeaks revelations exposing the rapidly growing corporatism dominating American diplomacy abroad

    One of WikiLeaks’ greatest achievements has been to expose the exorbitant amount of influence that multinational corporations have over Washington’s diplomacy.

  • 27-Jun-2011
    US breaks UN AIDS summit commitment on access to treatment

    The Asia Pacific Network of Positive People (APN+) is expressing outrage at ongoing free trade agreement negotiations by the United States with Vietnam and Malaysia that threaten access to medicines for HIV, TB, hepatitis-C as well as other diseases in these countries.

  • 23-Jun-2011
    The Bangkok Declaration on free trade agreements & access to medicines

    Statement of May 2011 against the increasingly rapid spread of Free Trade Agreements that put the profits of multinational pharmaceutical companies ahead of people’s right to health around the world.

  • 23-Jun-2011 MSF
    India says ‘no’ to policy that would block access to affordable medicines

    India formally announced at the UN High Level Meeting on HIV and AIDS that it will not accept data exclusivity, a provision harmful to access to affordable medicines, as part of a free trade agreement currently being negotiated with the European Union.

  • 16-Jun-2011 Infojustice
    Shape of US TPP pharmaceuticals chapter emerges

    The TPP chapter may be best seen as a significant step toward the pharmaceutical industry’s ultimate goal, which is a binding international agreement on drug pricing that would restrain the ability of governments to use collective purchasing power to demand prices below “market” levels.

  • 9-Jun-2011
    Pharmac trade row heralds wider threat

    Pharmac is being targeted by US drug companies as trade negotiations continue with the United States.

  • 8-Jun-2011 PharmaBiz
    Health groups call for moratorium on FTAs, TRIPS-plus measures by developed nations

    As the global community meets in New York for the United Nations General Assembly High Level Meeting on HIV and AIDS from 8 to 10 June 2011, networks of People living with HIV, health groups and treatment activists from around the world are calling for an immediate moratorium on all Free Trade Agreements (FTAs) and TRIPS-plus measures.

  • 2-Jun-2011
    Wrestling with Big Pharma

    Canadians spend a lot of money (public and private) on health care and much of that is spent on drugs — some $23.4 billion in 2008. Provincial insurance plans are desperately trying to cope, looking to initiatives like the recently passed Ontario law that caps prices of generic drugs at 25 per cent of the brand name equivalent.

  • 30-May-2011
    Goff: Pharmac ’absolute bottom line’

    Labour leader Phil Goff says his party would not put government drug buying agency Pharmac on the block to gain a free trade deal with the United States.

  • 29-May-2011 KEI
    Karl De Gucht writes Andris Piebalgs on topic of European Union IPR demands on India and other developing countries

    KEI has received a copy of a May 16, 2011 letter from Karl De Gucht to Andris Piebalgs, which discusses (1) the EU-India FTA, and (2) Relations between IPR and development policies.

  • 0 | ... | 40 | 60 | 80 | 100 | 120 | 140 | 160 | 180 | 200 | ... | 480